Title |
Doubling of median overall survival in a nationwide cohort of veterans with stage III non-small cell lung cancer in the durvalumab era.
|
---|---|
Published in |
Journal of Clinical Oncology, May 2021
|
DOI | 10.1200/jco.2021.39.15_suppl.8546 |
Authors |
Kamya Sankar, Alex K. Bryant, Michael Green, Nithya Ramnath |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 27% |
India | 4 | 18% |
United Kingdom | 2 | 9% |
Unknown | 10 | 45% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 10 | 45% |
Members of the public | 8 | 36% |
Practitioners (doctors, other healthcare professionals) | 4 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 33% |
Other | 1 | 17% |
Unknown | 3 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 17% |
Biochemistry, Genetics and Molecular Biology | 1 | 17% |
Medicine and Dentistry | 1 | 17% |
Unknown | 3 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2021.
All research outputs
#1,585,411
of 23,299,593 outputs
Outputs from Journal of Clinical Oncology
#3,898
of 20,282 outputs
Outputs of similar age
#42,056
of 445,067 outputs
Outputs of similar age from Journal of Clinical Oncology
#150
of 792 outputs
Altmetric has tracked 23,299,593 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,282 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,067 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 792 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.